CY2006006I2 - Πρωτεϊνικα σκευασματα - Google Patents

Πρωτεϊνικα σκευασματα

Info

Publication number
CY2006006I2
CY2006006I2 CY200600006C CY2006006C CY2006006I2 CY 2006006 I2 CY2006006 I2 CY 2006006I2 CY 200600006 C CY200600006 C CY 200600006C CY 2006006 C CY2006006 C CY 2006006C CY 2006006 I2 CY2006006 I2 CY 2006006I2
Authority
CY
Cyprus
Prior art keywords
protein formulations
formulations
protein
Prior art date
Application number
CY200600006C
Other languages
Greek (el)
English (en)
Other versions
CY2006006I1 (el
Original Assignee
Nps Allelix Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Allelix Corporation filed Critical Nps Allelix Corporation
Publication of CY2006006I1 publication Critical patent/CY2006006I1/el
Publication of CY2006006I2 publication Critical patent/CY2006006I2/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CY200600006C 1998-04-28 2006-10-23 Πρωτεϊνικα σκευασματα CY2006006I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801495A SE9801495D0 (sv) 1998-04-28 1998-04-28 Protein formulationa
PCT/CA1999/000376 WO1999055353A2 (en) 1998-04-28 1999-04-26 Protein formulations

Publications (2)

Publication Number Publication Date
CY2006006I1 CY2006006I1 (el) 2009-11-04
CY2006006I2 true CY2006006I2 (el) 2009-11-04

Family

ID=20411122

Family Applications (1)

Application Number Title Priority Date Filing Date
CY200600006C CY2006006I2 (el) 1998-04-28 2006-10-23 Πρωτεϊνικα σκευασματα

Country Status (24)

Country Link
US (1) US20050209144A1 (OSRAM)
EP (1) EP1079803B1 (OSRAM)
JP (2) JP4733267B2 (OSRAM)
KR (1) KR100579872B1 (OSRAM)
CN (1) CN1172658C (OSRAM)
AT (1) ATE273693T1 (OSRAM)
AU (2) AU766514B2 (OSRAM)
BR (1) BR9909958A (OSRAM)
CA (1) CA2329800C (OSRAM)
CY (1) CY2006006I2 (OSRAM)
DE (3) DE69919533T2 (OSRAM)
DK (1) DK1079803T3 (OSRAM)
ES (1) ES2224637T3 (OSRAM)
FR (1) FR06C0032I2 (OSRAM)
HK (1) HK1041218B (OSRAM)
IL (1) IL139320A (OSRAM)
LU (1) LU91281I2 (OSRAM)
NL (1) NL300243I2 (OSRAM)
NZ (1) NZ508269A (OSRAM)
PT (1) PT1079803E (OSRAM)
SE (1) SE9801495D0 (OSRAM)
SI (1) SI1079803T1 (OSRAM)
WO (1) WO1999055353A2 (OSRAM)
ZA (1) ZA200006040B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US20050032698A1 (en) * 2003-07-14 2005-02-10 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
EP1945245A2 (en) * 2005-11-10 2008-07-23 The Board of Control of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
DK2957278T3 (en) 2006-10-03 2017-07-31 Radius Health Inc STABLE COMPOSITION COMPREHENSIVE PTHRP AND APPLICATIONS THEREOF
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2925333B1 (fr) * 2007-12-19 2012-04-13 Farid Bennis Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
JP2009091363A (ja) * 2008-11-21 2009-04-30 Asahi Kasei Pharma Kk Ｐｔｈの安定化水溶液注射剤
EP2509996A1 (en) 2009-12-07 2012-10-17 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN103561757B (zh) * 2011-06-07 2016-01-06 旭化成制药株式会社 高纯度含pth冷冻干燥制剂及其制造方法
CN103301058A (zh) * 2013-06-17 2013-09-18 深圳翰宇药业股份有限公司 一种特立帕肽注射用组合物及其制备方法和制剂
SMT202300072T1 (it) 2014-03-28 2023-05-12 Univ Duke Cancro della mammella mediante l'utilizzo di modulatori selettivi del recetiore degli estrogeni
MX393599B (es) 2015-04-29 2025-03-19 Radius Pharmaceuticals Inc Rad1901 para usarse en el tratamiento de cancer en sujetos con cancer positivo a receptor de estrogeno alfa resistente a farmaco
CN106309358A (zh) * 2015-06-29 2017-01-11 成都金凯生物技术有限公司 含有人甲状旁腺激素的药物组合物及其制备方法与用途
CN117417263A (zh) 2017-01-05 2024-01-19 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
CN108333360A (zh) * 2017-01-19 2018-07-27 深圳市新产业生物医学工程股份有限公司 胃泌素释放肽前体稀释液及其应用和试剂盒
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
CA3075977C (en) * 2017-09-22 2024-10-29 Asahi Kasei Pharma Corporation LIQUID PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE WITH EXCELLENT STABILITY
CN108159404B (zh) * 2018-01-05 2019-08-27 北京博康健基因科技有限公司 重组人甲状旁腺激素制剂及其制备方法
CN112423844B (zh) 2018-07-04 2024-08-13 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
MA54946A (fr) 2019-02-12 2021-12-22 Radius Pharmaceuticals Inc Procédés et composés

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5744444A (en) * 1989-10-27 1998-04-28 Haemopep Pharma Gmbh HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
AU3095092A (en) * 1991-12-09 1993-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
JP2662842B2 (ja) * 1991-12-09 1997-10-15 旭化成工業株式会社 パラサイロイドホルモンの安定化組成物
DK0679088T3 (da) * 1992-09-29 2002-10-28 Inhale Therapeutic Syst Pulmonal levering af aktive fragmenter af parathyreoideaea hormon
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
JPH09157294A (ja) * 1995-06-15 1997-06-17 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
DE19538687A1 (de) * 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
JP4053107B2 (ja) * 1996-02-01 2008-02-27 中外製薬株式会社 血小板減少症の予防剤および治療剤
US5964807A (en) * 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa

Also Published As

Publication number Publication date
HK1041218B (zh) 2005-03-18
KR20010052276A (ko) 2001-06-25
PT1079803E (pt) 2004-11-30
AU2004200156A1 (en) 2004-02-12
DE122006000057I1 (de) 2007-01-04
JP2011105739A (ja) 2011-06-02
DE69919533T2 (de) 2005-09-08
WO1999055353A2 (en) 1999-11-04
DK1079803T3 (da) 2004-11-22
CY2006006I1 (el) 2009-11-04
WO1999055353A3 (en) 2000-01-13
CN1319003A (zh) 2001-10-24
BR9909958A (pt) 2000-12-26
IL139320A0 (en) 2001-11-25
CA2329800C (en) 2004-06-15
ES2224637T3 (es) 2005-03-01
SI1079803T1 (en) 2005-02-28
HK1041218A1 (en) 2002-07-05
JP2002512973A (ja) 2002-05-08
FR06C0032I1 (OSRAM) 2006-11-24
US20050209144A1 (en) 2005-09-22
AU2004200156B2 (en) 2005-12-15
CA2329800A1 (en) 1999-11-04
ATE273693T1 (de) 2004-09-15
EP1079803B1 (en) 2004-08-18
AU3591699A (en) 1999-11-16
JP5753692B2 (ja) 2015-07-22
FR06C0032I2 (fr) 2007-04-27
DE69919533D1 (de) 2004-09-23
LU91281I2 (fr) 2006-12-19
DE122006000057I2 (de) 2009-11-05
KR100579872B1 (ko) 2006-05-12
CN1172658C (zh) 2004-10-27
IL139320A (en) 2007-06-17
EP1079803A2 (en) 2001-03-07
NZ508269A (en) 2003-12-19
JP4733267B2 (ja) 2011-07-27
NL300243I1 (nl) 2006-12-01
SE9801495D0 (sv) 1998-04-28
ZA200006040B (en) 2002-01-28
NL300243I2 (nl) 2007-02-01
AU766514B2 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20004240L (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
DE69828330D1 (de) Aktiviertes Protein C Formulierungen
PT1130966E (pt) Formulacoes antiparasitarias
MA24473A1 (fr) Formulations
ID23299A (id) Formulasi-formulasi farmasi
EP1113799A4 (en) PROTEIN-BASED PREPARATION
IS2325B (is) Örgerðar samsetningar epleróns
NO982097L (no) Peptider
NO982098L (no) Peptider
ID29635A (id) Formulasi mikrokapsul
CY2006006I1 (el) Πρωτεϊνικα σκευασματα
DE69915204D1 (de) Stabilisierte Proteinzusammensetzung
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
ID27655A (id) Formulasi mikrokapsul
ATE217021T1 (de) Präparationsmittel
ATE246494T1 (de) Brausezubereitungen
ATE295417T1 (de) Angiostatin-bindendes protein
DK0862850T3 (da) Mejetærsker
NO20012283D0 (no) Koblede peptider
ID23663A (id) Persiapan kaprolaktam
DK1088069T3 (da) Angiostatin-bindende protein